SCHEMBL7642932

SCHEMBL7642932

CCCCOc1nsc(N[C@H](C(N)=O)[C@@H](C)CC)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
XDH P47989 1/20 0.32
HSPA5 P11021 1/20 0.31
HSPA2 P54652 1/20 0.31
ACACB O00763 1/20 0.31
LMNA P02545 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP13 P45452 1/20 0.31
MAPK8 P45983 1/20 0.31
MAPK1 P28482 2/20 0.30
POLB P06746 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400637 0.87 SMN1; SMN2 (0.33) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL7408062 0.85 XIAP (0.37) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL7408066 0.76 XIAP (0.55) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL7637777 0.76 ELANE (0.42) MAPK8CA12CA1CA9PPARG
SCHEMBL7406241 0.75 L3MBTL1 (0.36) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL7403583 0.74 L3MBTL1 (0.36) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A
SCHEMBL7400265 0.73 FCER2 (0.41)
SCHEMBL7642030 0.73 ELANE (0.42) POLB
SCHEMBL7644396 0.72 XIAP (0.43) XIAPSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL7403586 0.72 RAB9A (0.41) XIAPL3MBTL1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
CN-1291993-A Thiadiazole compounds useful as cysteine activity dependent enzyme inhibitors APOTEX INC (CA) 2001-04-18 CN disclosed